Man Group
DFTX

Man Group’s Definium Therapeutics DFTX Stock Holding History

Man Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-32,062
Closed -$231K – 2116
2024
Q2 		$231K Sell
32,062
-80,115
-71% -$701K ﹤0.01% 1856
2024
Q1 		$1.05M Buy
+112,177
New +$640K ﹤0.01% 1527
2023
Q1 		– Hold
0
– – – 1999
2022
Q2 		– Sell
-14,652
Closed -$185K – 1873
2022
Q1 		$244K Buy
14,652
+7,359
+101% +$128K ﹤0.01% 1853
2021
Q4 		$151K Buy
+7,293
New +$233K ﹤0.01% 1841

Other funds holding DFTX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's DFTX Position: Q3 2024 in Review

Man Group sold out of Definium Therapeutics (DFTX) in Q3 2024, closing a stake of 32,062 shares — an estimated $231K sold.

Man Group first reported a position in DFTX in Q4 2021 and held it in 4 quarters. The position peaked at $1.05M in Q1 2024. 157 funds tracked by Wall St. Rank hold DFTX as of Q3 2024.

  • Man Group reported no remaining Definium Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Man Group sold 32,062 Definium Therapeutics shares in Q3 2024, an estimated $231K.
  • Man Group first reported a position in Definium Therapeutics in Q4 2021 and held it in 4 quarters.
  • Man Group's Definium Therapeutics position peaked at $1.05M in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2024.

Based on Man Group's 13F filing for Q3 2024, filed 14 Nov 2024.